首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1297818

全球血管成形術球囊市場 - 2023-2030年

Global Angioplasty Balloons Market - 2023-2030

出版日期: 2023年06月15日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球血管成形術球囊市場在2022年達到22億美元，預計到2030年將見證有利可圖的成長，達到29億美元。在預測期內（2023-2030年），全球血管成形術球囊市場預計將呈現3.5%的複合成長率。

血管成形術球囊主要用於治療冠狀動脈疾病（CAD），這種疾病是由於斑塊在動脈內堆積，導致其變窄或堵塞而發生的。用球囊進行血管成形術是一種微創手術，可以通過皮膚上的一個小切口進行，通常在腹股溝或手腕部位。

生活方式相關疾病的發生率增加和對微創手術的需求增加等因素，預計將推動市場發展。此外，先進技術的迅速採用，特別是在已開發國家，在血管成形術領域，包括這種藥物洗脫和切割球囊，估計將推動整個預測期的市場成長。

市場動態

對公司戰略和研發的進一步關注將推動市場成長

對公司戰略和研發的日益關注將推動市場的成長。例如，2021年6月17日，部門資產管理公司向Cagent Vascular Inc.投資900萬美元，該公司是採用獨特鋸齒技術的下一代血管成形術球囊的生產商。除投資外，Marc-Andre Marcotte已加入董事會。這些資金將用於加快Serranator膝下型（BTK）產品的商業化和規模化。

此外，2022年4月22日，Accumed Radial Systems宣布與POBA Medical, Inc.達成戰略協議，為我們的創新、專有和改變遊戲規則的Accumed Radial Intra Vascular Extension（ARIVE）技術創造原型。 POBA將與Accumed Radial團隊合作，為多種應用建立ARIVE原型，同時提供設計、製造和擴大規模的專業知識。 POBA將同時對Accumed Radial進行投資。上述因素預計將在預測期內推動市場擴張。

冠狀動脈和周邊動脈疾病發病率的增加可能會促進市場成長

周邊和冠狀動脈疾病是動脈粥樣硬化的常見症狀，可導致中風、心肌梗塞和/或心血管疾病的死亡。這些疾病的發病率不斷上升，預計將在接下來的幾年裡推動市場擴張。根據CDC的數據，冠心病是最常見的心臟病類型，到2021年約有375,000人死亡。 20歲及以上的人中，大約每20人中就有1人受CAD影響。

2021年，每10個死於CAD的人中有近2個將發生在65歲以下的人身上。因此，冠心病正在上升，促進了市場成長。

血管成形術的高成本和術後併發症可能會阻礙市場成長

與血管成形術相關的高成本和術後困難預計將扼殺市場擴張。根據美國國家醫學圖書館的數據，每次手術的平均總費用（包括門診費用）為21,893美元，而且血管成形術後6至10小時內會出現再狹窄、心臟病發作、心室顫動、心肌梗塞、支架錯位、動脈瘤、腎衰竭和癲癇發作等併發症。這些因素可能會阻礙市場成長。

COVID-19影響分析

根據2020年9月發布的一項研究，目前COVID-19大流行期間的心臟手術對心臟病人和護理這些病人的醫護人員都構成了綜合危險，因為他們現在因COVID-19而出現併發症的風險更高。此外，美國外科醫生學會和美國麻醉師學會建議在COVID-19檢測結果出來後，將選擇性心臟手術推遲至少14天。

由於圍繞COVID-19的各種考慮，預計選擇性血管成形手術將被暫停，從而影響血管成形球囊的使用。在此期間，市場可能會經歷很少，如果有的話，成長。

俄羅斯-烏克蘭戰爭影響分析

俄羅斯-烏克蘭估計對全球血管成形術球囊市場的影響很小，因為該地區流行率低，沒有主要市場參與者。然而，在預測期內，原料、測試產品和設備的進出口的影響預計對全球血管成形術球囊市場的影響很小。

人工智慧影響分析

人工智慧預計將對全球血管成形術球囊市場產生積極的影響。由於人工智慧算法可以分析醫療圖像，如血管造影或電腦斷層掃描（CTA）掃描，以協助識別和定位血管內的病變或堵塞。

這種分析通過深入了解堵塞物的大小、位置和嚴重程度，幫助介入心臟病專家規劃血管成形術。值得注意的是，雖然人工智慧在協助血管成形球囊手術方面顯示出巨大的潛力，但它應始終作為一種工具來支持醫療保健專業人士，而不是取代他們的專業知識和判斷。

Market Overview

The Global Angioplasty Balloons Market reached US$ 2.2 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 2.9 billion by 2030. The global angioplasty balloons market market is expected to exhibit a CAGR of 3.5% during the forecast period (2023-2030).

Angioplasty balloons are primarily used in the treatment of coronary artery disease (CAD), which occurs due to the buildup of plaque within the arteries, leading to their narrowing or blockage. Angioplasty with balloons is a minimally invasive procedure that can be performed through a small incision in the skin, often in the groin or wrist area.

Factors such as the increased occurrence of lifestyle-related disorders and the increasing demand for minimally invasive procedures are anticipated to propel the market. Moreover, the Rapid adoption of advanced technologies, particularly in the developed world, in the angioplasty segment, including such drug-eluting and cutting balloons, is estimated to drive market growth throughout the forecast period.

Market Dynamics

The Increased Focus on Companies Strategies and R&D will Drive the Market Growth

The increased focus on companies strategies and R&D will drive the market growth. For instance, on June 17, 2021, Sectoral Asset Management has made a $9 million investment in Cagent Vascular Inc., a producer of next generation angioplasty balloons using unique serration technology. Marc-Andre Marcotte has joined the board of directors in addition to the investment. The funds will be used to expedite the commercialization and scaling of the Serranator below-the-knee (BTK) product.

Additionally, on April 22, 2022, Accumed Radial Systems announce a strategic agreement with POBA Medical, Inc. to create prototypes of our innovative, proprietary, and game-changing Accumed Radial Intra Vascular Extension (ARIVE) technology. POBA will collaborate with Accumed Radial teams to build ARIVE prototypes for multiple applications, while providing design, manufacturing, and scale-up expertise. POBA will invest in Accumed Radial at the same time. The aforementioned factors are projected to fuel market expansion over the forecast period.

Increasing Incidence of Coronary and Periphery Artery Diseases is Likely to Boost the Market Growth

Peripheral and coronary artery disease are frequent symptoms of atherosclerosis and can lead to stroke, myocardial infarction, and/or death from cardiovascular disease. The rising prevalence of these disorders is expected to drive market expansion in the following years. According to the CDC, coronary heart disease is the most frequent type of heart disease, killing around 375,000 individuals by 2021. CAD affects about one in every twenty persons aged 20 and over.

In 2021, almost 2 out of every 10 deaths from CAD will occur in persons under the age of 65. As a result, coronary heart disease is on the rise, contributing to market growth.

High Costs And the Post-Operational Complications Associated with Angioplasty are Likely to Hamper the Market Growth

High costs and post-operative difficulties associated with angioplasty are expected to stifle market expansion. According to the National Library of Medicine, the average total charge per procedure, including outpatient charges, was $21,893, and complications such as restenosis, heart attack, ventricular fibrillation, myocardial infarction, misplacement of a stent, aneurysms, kidney failure, and seizures occurred within 6 to 10 hours of angioplasty. These elements are likely to hinder market growth.

COVID-19 Impact Analysis

According to a study released in September 2020, cardiac surgery during the present COVID-19 pandemic poses a combined danger for both cardiac patients, who are now at a higher risk of complications due to COVID-19, and the healthcare staff who care for these patients. Furthermore, the American College of Surgeons and the American Society of Anesthesiologists recommended postponing elective heart surgery for at least 14 days following a COVID-19 test result.

As a result of the various considerations surrounding COVID-19, elective angioplasty surgeries are projected to be suspended, affecting the use of angioplasty balloons. During this period, the market may experience little, if any are present, growth.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global angioplasty balloons market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global angioplasty balloons market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact the global angioplasty balloons market positively . Due to AI algorithms can analyze medical images, such as angiograms or computed tomography angiography (CTA) scans, to assist in the identification and localization of lesions or blockages within the blood vessels.

This analysis helps the interventional cardiologist in planning the angioplasty procedure by providing insights into the size, location, and severity of the blockage. It's important to note that while AI shows great potential in assisting with angioplasty balloon procedures, it should always be used as a tool to support healthcare professionals rather than a replacement for their expertise and judgment.

Segment Analysis

The global angioplasty balloons market is segmented based on product type, application, end user, and region.

The Hospital Segment is Estimated to Hold around 34.5% of the Angioplasty Balloons Market Share During the Forecast Period

The hospital segment holds about 34.5% of the total angioplasty balloons market in the forecast period. The significant increase in the older population suffering from lifestyle disorders including atherosclerosis and heart failure is predicted to increase the patient pool and boost hospital income production. Furthermore, as compared to traditional operations, the numerous benefits of minimally invasive surgeries, such as reduced surgical discomfort, injury, scarring, hospital stay, higher accuracy, and faster recovery time, motivate more patients to choose minimally invasive balloon angioplasty surgeries.

For instance, according to the American College of Cardiology, roughly 2.1 million angioplasties are performed in the United States per year in 2020. Furthermore, hospitals are likely to attract a big patient base due to their greater accessibility and affordability when compared to speciality clinics. All of these factors are projected to have an impact on segment growth.

Geographical Analysis

North America is Estimated to Hold the Largest Share of the Global Angioplasty Balloons Market During the Forecast Period

The North America region holds the largest share of the global angioplasty balloons market accounting for approximately 40.1% in the forecast period. North America accounted for the maximum revenue share in the angioplasty balloons market. The presence of key industry players, the rising healthcare expenditure, and the increasing product approvals by regulatory bodies in the United States are expected to drive the market's growth.

For instance, on January 2, 2023, the Stellarex 0.035 OTW Drug-coated Angioplasty Balloon from Philips Image Guided Therapy Corp. has been approved by the US Food and Drug Administration (FDA). Stellarex 0.035 OTW Drug-coated angioplasty balloon (Stellarex 035 DCB) reopens blocked or restricted arteries in the thigh and knee caused by peripheral arterial disease (PAD). These advancements are projected to strengthen the region's market's robust product portfolio.

Competitive Landscape

The major global players in the market include: Boston Scientific Corporation, BIOTRONIK, Medtronic Plc, Cordis (Cardinal Health), Terumo Corporation, Abbott Laboratories, AngioDynamics, BD, INFINITY Angioplasty Balloon, and Koninklijke Philips N.V, among others.

Why Purchase the Report?

To visualize the global angioplasty balloons market segmentation based on product type, application, end user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of angioplasty balloons market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global angioplasty balloons market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing incidence of coronary and periphery artery diseases
  - 4.1.1.2. The increased focus on companies strategies and R&D
- 4.1.2. Restraints
  - 4.1.2.1. High costs and the post-operational complications associated with angioplasty
- 4.1.3. Opportunity
  - 4.1.3.1. Preference for minimally invasive procedures
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario before COVID-19
- 6.1.2. Scenario during COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Impact Analysis

9. By Product Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 9.1.2. Market Attractiveness Index, By Product type
9.2. Drug Eluting Balloons
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Normal Balloons
9.4. Cutting/Scoring Balloons

10. By Application

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.1.2. Market Attractiveness Index, By Application
10.2. Coronary Angioplasty
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Peripheral Angioplasty

11. By End User

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Ambulatory Surgical Centers
11.4. Others

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.6.1. The U.S.
  - 12.2.6.2. Canada
  - 12.2.6.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.6.1. Germany
  - 12.3.6.2. The U.K.
  - 12.3.6.3. France
  - 12.3.6.4. Italy
  - 12.3.6.5. Spain
  - 12.3.6.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.6.1. Brazil
  - 12.4.6.2. Argentina
  - 12.4.6.3. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.6.1. China
  - 12.5.6.2. India
  - 12.5.6.3. Japan
  - 12.5.6.4. Australia
  - 12.5.6.5. Rest of Asia-Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. Boston Scientific Corporation
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. BIOTRONIK
14.3. Medtronic Plc
14.4. Cordis (Cardinal Health)
14.5. Terumo Corporation
14.6. Abbott Laboratories
14.7. AngioDynamics
14.8. BD
14.9. INFINITY Angioplasty Balloon
14.10. Koninklijke Philips N.V.

LIST NOT EXHAUSTIVE